This week in Hospital and Healthcare: AI makes its presence felt in MedTech as it accelerates drug discovery efforts and enables precision surgery
Latest Industry Insights from Draup Braindesk
Pharma companies focus on enhancing product portfolios and expanding drug research through several investments to provide high-end services for consumers.
Companies are using Health gamification to motivate everybody to live a healthier life.
Otsuka leverages spencer’s smart hub, an at-home medication device that connects patients and care teams for the virtual clinical facility.
Regeneron collaborated with Sanofi to research, develop, and commercialize antibody-based cancer treatments in the field of Immuno-oncology.
Cerner Corporation partnered with Amazon to bring cloud-based health tracking services to its electronic health record customers.
Cytiva partnered with Multiply labs to develop a robotic manufacturing system and automate the manual portions of the cell therapy manufacturing workflow.
Latest Reports Published in Draup
Cerner Corporation Account Intelligence Report: Cerner Corporation aims to develop clinically-driven A.I. techniques with proven predictive model outcomes to serve the health care sector.The company also focuses on developing advanced Electronic Health Record Systems (EHR) to track all the aspects of health care and make data-driven decisions. Read More>>
Stryker Account Intelligence Report:
Stryker intends to offer solutions that allow surgeons to perform surgery through precision, visibility, and flexibility using an array of instruments. The focus area remains on surgical procedures and safety in operating rooms. Stryker intends to deploy protective solutions for patients and surgical solutions for surgeons to ensure safe and precise surgeries. Read More>>
Key Funding Alert
Funding Alert: Xilis raises USD 70 Mn Series A financing to advance Diagnostic and Drug Discovery and Development Platform
The financing was led by Mubadala Capital and included new investors G.V. (formerly Google Ventures), European healthcare investment firm LSP, Catalio Capital Management, and Duke Angel Network. Xilis will use the raised funds to advance its MicroOrganoSphere (MOS) technology, expand machine learning capabilities, conduct clinical trials using its technology, and validate its use in drug development with pharmaceutical partners. Read More>>
Company – Sonoma Biotherapeutics Total Funding– USD 70 Mn HQ Location – San Francisco Bay Area, USA Year of Inception – 2020 About: Sonoma Biotherapeutics is involved in developing adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next-generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Read More>>
Key Insights and Signals – Hospital & Healthcare
Centre setup and Expansion Amedisys to open Westchester County home Healthcare center Amedisys will operate certified home health care services in Westchester County, NY, and the New York borough of the Bronx. The new care center will provide access to 375,000 Medicare enrollees and 165,000 Medicare Advantage enrollees. Read More>> HCA Healthcare to build USD 50 Mn Hospital for Endocrine Surgery in Tampa The company plans to build Florida’s first Hospital for Endocrine Surgery in a USD 50 Mn expansion of the Memorial Hospital of Tampa campus. The Hospital will be a “one-stop-shop” for physicians to refer patients with endocrine tumors of varying complexities and welcome patients by January. Read More>> Mayo Clinic expands offerings at London clinic The company is adding several medical specialties to its offerings, including cardiology, gastroenterology, and pulmonary medicine. This clinic will be a gateway to Mayo Clinic’s roughly 4,000 physicians in the United States and a hub for virtual visits. Read More>>Deal and Deal Renewal Clinical Pathways expanded to include Data Collection, EHR Management at Geisinger Geisinger implemented Elsevier’s ClinicalPath in medical and radiation oncology in April 2019. The pathways product was rolled out at all sites a month later. The health system decided to integrate ClinicalPath into its Epic electronic health record (EHR) management system because incorporating into the workflow was critical to getting physicians to adopt pathways. Read More>> Merck KGaA taps Spanish graphene startup for ultrafine, innovative neuromodulation therapies Inbrain Neuroelectronics has been developing a system that employs incredibly fine electrodes at only one atom thick to allow an implant to deliver minimally invasive electrical stimulation. Working with its subsidiary, Innervia Bioelectronics, the German Merck aims to produce new therapies based around the vagus nerves, which help link the brain with the heart, lungs, and digestive tract. Read More>>Merger and Acquisition SoftBank eyes stake in Apollo Hospitals’ pharmacy arm SoftBank is in talks to acquire a stake in Apollo Hospitals Enterprise Ltd’s pharmacy arm Apollo HealthCo as part of the Japanese company’s focus on India’s healthcare market. Apollo is looking to sell about a 25 percent stake in the company. The talks are at a preliminary stage, and SoftBank is one of the investors in a race to acquire the stake. Read More>> Craneware completes acquisition of Sentry Data Systems As a result of this acquisition, Craneware now serves nearly 40 percent of U.S. hospitals and more than 10,000 clinics and retail pharmacies across all the major pharmacy brands as well as local community pharmacies and clinics. By combining solutions of both companies, Craneware will deliver far-reaching actionable insights for better operational and strategic decisions. Read More>>Partnerships Seniors First partners with 1MG and Thyrocare The partnership will allow all the members of Seniors First to avail themselves of wide-ranging services, including tests, health insurance products, lifestyle, and medical products, exclusively for senior citizens all over India. A dedicated customer care service for non-tech-savvy senior citizens will assist the elderly in requesting medicines and diagnostic services. Read More>> Baystate Health collaborates with Cerner to advance Digital Health and accelerate consumer-focused care This digital innovation will help improve patient access to personalized care, provide clinicians with clearer views into patient populations, and use data to drive more effective disease management and virtual health experiences. Revenue cycle management solutions and Cerner’s HealtheIntent will be some of the digital initiatives to start with. Read More>> Theator and Mayo Clinic collaborate to improve surgeon performance The strategic collaboration follows Mayo Clinic’s investment in Theator’s USD 15.5 Mn Series A funding round earlier this year. Theator’s AI-powered platform streamlines surgical video capture and analysis, transforming video data into indexed insights. The collaboration will enable Theator to broaden its surgical intelligence platform’s capabilities for use in urology and gynecology. Read More>>Executive Movement ProMedica names Angela Brandt as senior care division President Brandt, who has nearly 25 years of health care industry experience, most recently served as president of ProMedica Physicians. As President, She is tasked with making strategic senior care investments, working with other ProMedica divisions, and seeking new partnerships and ventures. Read More>> Syneos Health appoints Chief Development Officer Micheal Brooks, previously president and global head of LabCorp (Covance), is now joining Syneos Health as a Chief Development Officer. In this new role, Brooks will help drive Syneos’ growth strategy, building a broader, proactive go-to-market ecosystem while leading the company’s customer engagement and market development portfolio. Read More>> McLaren Health Care names new Chief Operating Officer Chad Grant was named the new Executive Vice President and Chief Operating Officer for McLaren Health Care. Grant brings extensive healthcare leadership experience, including successful management of acute care hospital operations, strategic planning, new business development, and change management. Read More>>
Key Insights and Signals in Pharmaceuticals
Centre setup and expansion GSK to establish a new life science campus in the U.K. GSK plans to sell 33 acres of land in the area to raise USD 551 Mn. GSK intends to choose a development partner later this year and begin planning for the facility in 2022. The facility could create up to 5,000 life science research and development jobs over the next five to 10 years. Read More>> Regeneron plans USD 1.8 Bn investment to expand research facilities in New York, US The company intends to expand its research, preclinical manufacturing, and support facilities in Tarrytown, New York, creating approximately 1,000 more full-time jobs in the region over the next five years. The project involves adding new preclinical manufacturing and process development suites, office space, and laboratories. Read More>>Deals and Deal Renewals Shionogi and HanaVax enter into a license agreement for COVID-19 vaccine development cCHP is HanaVax’s unique delivery technology that can effectively induce immunity in the respiratory mucosa, and the whole body, without the pain caused by conventional injections since it delivers the dose intranasally. From the viewpoint of easy medical access, there is an increasing need for a nasal vaccine, especially in emerging countries. Read More>> OPKO Health inks licensing deal for AntagoNAT technology This exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) aims to develop, manufacture, and commercialize therapeutics using the former’s AntagoNAT technology. The deal is expected to significantly strengthen OPKO Health’s foothold in the global Oligonucleotide Therapeutics business. Read More>> BioNTech returns to cancer roots with deal for Gilead cell therapy factory BioNTech, the German drug developer, will buy a cancer cell therapy factory and related research from Gilead’s Kite Pharma unit. Besides the coronavirus vaccine, all of its drugs currently in human testing are for cancer. This deal reflects BioNTech’s continued commitment to its roots in cancer drug research, particularly cell-based immunotherapies. Read More>>Merger and Acquisition Curia acquires LakePharma Inc to provide R&D to Biotech, Pharma companies Curia has entered into a definitive agreement to acquire LakePharma Inc. The new company’s six facilities and 235 employees will join Curia’s 21 sites and more than 3,100 employees. LakePharma will expand Curia’s integrated approach to provide biotech and pharmaceutical companies with small and large molecule research, development, and manufacturing solutions. Read More>> Eli Lilly buys Protomer technologies for a value that could be above USD 1 Bn Protomer’s proprietary molecular engineering of protein sensors (MEPS) platform helps develop glucose-responsive insulin that can sense sugar levels in the blood and automatically activate as needed. Lilly had already invested in a 14% stake earlier, and subject to the achievement of certain developments and milestones, the whole acquisition could potentially be valued at USD 1 Bn. Read More>> Brazil’s Hypera buys OTC products from Sanofi for USD 190 Mn Hypera has acquired 12 over-the-counter (OTC) and prescription brands in Latin America from France’s Sanofi. Among the brands acquired are mouthwash Cepacol and antipyretic AAS. Hypera is also buying drugs to treat epilepsy. Read More>>Partnerships AbbVie, Biogen, Pfizer launch public database linking genes and diseases Researchers at AbbVie, Biogen, and Pfizer provided data and guidance for single-variant and gene-based association testing spanning 3,817 phenotypes, built on data gathered from the U.K. Biobank. The Genebass database allows users to browse through the genes associated with different conditions—such as levels of HDL, or good cholesterol, platelets, and RBC counts. Read More>> Verge Genomics, Eli Lilly partner to develop ALS therapies The companies entered a three-year partnership to discover and develop novel therapies for amyotrophic lateral sclerosis (ALS), a motor neuron disease. As part of the collaboration, Verge plans to apply its all-in-human platform to discover and validate new targets for ALS, which currently has no cure. Read More>>Executive Movement Clovis Oncology appoints Dr. Ronit Simantov to its Board Dr. Simantov’s extensive background and experience will support Clovis’ key strategic priorities to advance both Rubraca’s pipeline into a potentially broader label and the company’s early-stage pipeline of targeted radiotherapy candidates into clinical development. Dr. Simantov has recently served as Chief Medical Officer of Gamida Cell Ltd. Read More>> Pfizer announces new Investor Relations Leader Christopher Stevo has joined Pfizer as Senior Vice President and Chief Investor Relations Officer. Mr. Stevo has held leadership positions in buy-side healthcare investing for more than two decades, most recently serving as Head of Investor Relations for Alexion Pharmaceuticals. Read More>> Corcept Therapeutics picks Former Gilead Science exec as the new Chief HR and Communications Officer Amy Flood will be joining Corcept Therapeutics as Chief HR and Communications Officer. Ms. Flood has nearly 25 years of experience in team development and communications in the biotech industry and has spent almost 21 years at Gilead Sciences, most recently as Senior V.P., Public Affairs. Read More>>
Key Insights and Signals in MedTech
Centre setup and expansion Zeiss Vision Care celebrates ribbon cutting on new U.S. headquarters in Hebron Lens producer Zeiss Vision Care capped off a multi-year, USD 20 Mn construction project with a ribbon-cutting ceremony at the company’s new U.S. Headquarters in Hebron. The expansion primarily involved updates to the company’s state-of-the-art optical laboratory, which uses automation, robotics, and big-data machine learning to produce lenses quickly and with little manual intervention. Read More>> MedTech firm Konica Minolta launches Cloud data center services This Infrastructure as a Service (IaaS) package enables organizations to reduce costs and effort relating to their I.T. infrastructure while maximizing security and driving a total digital transformation. The package delivers a virtual I.T. infra environment, including a virtual network, storage, and server resources in Konica Minolta’s data centers. Read More>>Deals and renewals Agilent Technologies, Thomas Scientific Ink distribution agreement for Genomics products Under the agreement, Thomas Scientific will be able to offer its customers access to more than 700 Agilent bioreagent products, including qPCR instruments, reagents, PCR enzymes, and other molecular biology reagents. Read More>> Celularity partners with Arthrex for distribution of ortho and sports biomaterial products Under the agreement, Arthrex will have exclusive commercial distribution rights to Celularity’s biomaterial products for orthopedic surgery and sports medicine. Celularity is a biotechnology company creating cell therapies and biomaterial products. Per the agreement, Celularity will remain in charge of product manufacturing and supply. Read More>>Partnerships PacBio and Invitae intend to expand collaboration The expansion of the multi-year collaboration between Invitae and Pacific Biosciences is to develop a production-scale high-throughput HiFi sequencing platform to include the sequencing technology developed by Omniome, Inc. Omniome’s sequencing technology promises significant improvement in raw base accuracy over traditional sequencing products enabling the potential for more precise and sensitive molecular diagnostics. Read More>> RTI Surgical and Exactech announce strategic partnership As part of the agreement, RTI Surgical has acquired Exactech’s Optecure, a 510(k)- cleared demineralized bone matrix for use as a bone graft extender in the spine, pelvis, and extremities. Optecure will complement RTI Surgical’s market-leading portfolio of bone graft substitutes. Optecure is RTI Surgical’s first product acquisition since Montagu acquired the company in 2020. Read More>>Merger and Acquisition Becton Dickinson (BDX) acquires Velano Vascular With Velano Vascular’s needle-free technology that enables high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines, BDX can now facilitate health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort and build on the vision of “One-stick hospital stay.” Read More>> Pacific Biosciences to buy Omniome for USD 800 Mn Adding Omniome’s short-read sequencing technology to PacBio’s long-read portfolio will enable the company to expand its total market opportunity. Post this acquisition, PacBio will be uniquely positioned as the only company with both highly accurate long-read and short-read sequencing platforms. The acquisition will be valued at USD 800 Mn to be delivered in cash and stocks. Read More>>Executive Movement Omnicell appoints Edward Bousa to its Board The MedTech firm has appointed Edward P. Bousa to fill the newest seat of the company’s Board of Directors. Mr. Bousa is a renowned value portfolio manager who brings nearly four decades of experience in institutional asset management. He will serve as an independent director and as a member of the Board’s Corporate Governance Committee. Read More>> Becton Dickinson names non-exec Chairman for planned Spin-off The company has named David Melcher to helm the board of its Diabetes Care business it plans to spin off into an independent, listed company. Mr. Melcher brings substantial executive experience from years in leadership positions in the defense sector and has extensive experience in spin-offs. Read More>>
Here’s what’s new on our Sales Intelligence Platform Easy Access To Executive Movements
Get to know executive movements in accounts in your lists through the Homepage feed